Lataa...
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivat...
Tallennettuna:
| Julkaisussa: | Front Endocrinol (Lausanne) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319972/ https://ncbi.nlm.nih.gov/pubmed/28275367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00031 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|